ras mutation and platinum resistance in human ovarian carcinomasin vitro
- 3 July 1998
- journal article
- Published by Wiley in International Journal of Cancer
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.British Journal of Cancer, 1998
- Phosphorylation of Bcl-2 Protein and Association with p21Ras in Ras-induced ApoptosisOnline Journal of Public Health Informatics, 1996
- Oncogenic transformation alters cisplatin‐induced apoptosis in rat embryo fibroblastsInternational Journal of Cancer, 1995
- Differential Na+, K+-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-rasInternational Journal of Cancer, 1994
- Mutagenesis in monkey cells of a vector containing a single d(GPG)cis-diamminedichloroplatinum(ll) adduct placed on codon 13 of the humanH-rasproto-oncogenNucleic Acids Research, 1994
- DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cellsNucleic Acids Research, 1994
- A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell linesEuropean Journal of Cancer, 1993
- Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availabilityBritish Journal of Cancer, 1993
- Resistance of human larynx carcinoma cells to cisplatin, γ-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenesMutation Research Letters, 1993
- Point Mutation of the ras Oncogene in Human Ovarian CancerDNA and Cell Biology, 1993